Krka D.D. Novo Mesto
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- ESOMEPRAZOLE KRKA gastro-resistant capsule, hard 20 mg
- ESOMEPRAZOLE KRKA gastro-resistant capsule, hard 40 mg
- RABEPRAZOLE KRKA gastro-resistant tablet 20 mg
- A10 - Antidiabéticos
- ENYGLID tablet 0.5 mg
- ENYGLID tablet 1 mg
- REPAGLINIDE KRKA tablet 0.5 mg
- REPAGLINIDE KRKA tablet 1 mg
- C09 - Agentes activos sobre el sistema renina-angiotensina
- CANDESARTAN HYDROCHLOROTHIAZIDE KRKA tablet 16 mg+12.5 mg
- CANDESARTAN HYDROCHLOROTHIAZIDE KRKA tablet 32 mg+12.5 mg
- CANDESARTAN HYDROCHLOROTHIAZIDE KRKA tablet 32 mg+25 mg
- CANDESARTAN HYDROCHLOROTHIAZIDE KRKA tablet 8 mg+12.5 mg
- CANDESARTAN KRKA tablet 16 mg
- CANDESARTAN KRKA tablet 32 mg
- CANDESARTAN KRKA tablet 4 mg
- CANDESARTAN KRKA tablet 8 mg
- IFIRMASTA film-coated tablet 150 mg
- IFIRMASTA film-coated tablet 300 mg
- IFIRMASTA film-coated tablet 75 mg
- LOZARTAN HYDROCHLOROTHIAZIDE KRKA film-coated tablet 100 mg+12.5 mg
- LOZARTAN KRKA film-coated tablet 100 mg
- LOZARTAN KRKA film-coated tablet 12.5 mg
- LOZARTAN KRKA film-coated tablet 25 mg
- LOZARTAN KRKA film-coated tablet 50 mg
- TOLURA tablet 40 mg
- TOLURA tablet 80 mg
- VALSARTAN KRKA film-coated tablet 160 mg
- VALSARTAN KRKA film-coated tablet 320 mg
- VALSARTAN KRKA film-coated tablet 40 mg
- VALSARTAN KRKA film-coated tablet 80 mg
- C10 - Agentes modificadores de los lípidos
- ATORVASTATIN KRKA film-coated tablet 10 mg
- ATORVASTATIN KRKA film-coated tablet 20 mg
- ATORVASTATIN KRKA film-coated tablet 40 mg
- ATORVASTATIN KRKA film-coated tablet 60 mg
- ATORVASTATIN KRKA film-coated tablet 80 mg
- G04 - Urológicos
- VIZARSIN film-coated tablet 100 mg
- VIZARSIN film-coated tablet 25 mg
- VIZARSIN film-coated tablet 50 mg
- J05 - Antivirales de uso sistémico
- DARUNAVIR KRKA film-coated tablet 600 mg
- DARUNAVIR KRKA film-coated tablet 800 mg
- EFAVIRENZ EMTRICITABINE TENOFOVIR KRKA film-coated tablet 600 mg+200 mg+245 mg
- EMTRICITABINE TENOFOVIR DISOPROXIL KRKA film-coated tablet 200 mg+245 mg
- L01 - Antineoplásicos
- PEMETREXED KRKA powder for solution for infusion 100 mg
- PEMETREXED KRKA powder for solution for infusion 500 mg
- L04 - Inmunosupresores
- LENALIDOMIDE KRKA capsule, hard 10 mg
- LENALIDOMIDE KRKA capsule, hard 15 mg
- LENALIDOMIDE KRKA capsule, hard 25 mg
- LENALIDOMIDE KRKA capsule, hard 5 mg
- N02 - Analgésicos
- PRAGIOLA capsule, hard 150 mg
- PRAGIOLA capsule, hard 300 mg
- N04 - Antiparkinsonianos
- OPRYMEA prolonged-release tablet 0.26 mg
- OPRYMEA prolonged-release tablet 0.52 mg
- OPRYMEA prolonged-release tablet 1.05 mg
- OPRYMEA prolonged-release tablet 2.1 mg
- OPRYMEA prolonged-release tablet 2.6 mg
- OPRYMEA prolonged-release tablet 3.15 mg
- OPRYMEA tablet 0.088 mg
- OPRYMEA tablet 0.18 mg
- OPRYMEA tablet 0.35 mg
- OPRYMEA tablet 0.7 mg
- RASAGILINE KRKA tablet 1 mg
- N05 - Psicolépticos
- ARIPIPRAZOLE KRKA tablet 10 mg
- ARIPIPRAZOLE KRKA tablet 15 mg
- ARIPIPRAZOLE KRKA tablet 30 mg
- ZALASTA tablet 10 mg
- ZALASTA tablet 5 mg
- N06 - Psicoanalépticos
- DONEPEZIL KRKA film-coated tablet 10 mg
- DONEPEZIL KRKA film-coated tablet 5 mg
- DULSEVIA gastro-resistant capsule, hard 30 mg
- DULSEVIA gastro-resistant capsule, hard 60 mg
- MARIXINO film-coated tablet 10 mg
- MARIXINO film-coated tablet 20 mg
- NIMVASTID capsule, hard 1.5 mg
- NIMVASTID capsule, hard 3 mg
- NIMVASTID capsule, hard 4.5 mg
- NIMVASTID capsule, hard 6 mg
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- MONTELUKAST KRKA chewable tablet 4 mg
- MONTELUKAST KRKA chewable tablet 5 mg
- MONTELUKAST KRKA film-coated tablet 10 mg
- R06 - Antihistamínicos para uso sistémico
- DASSELTA film-coated tablet 5 mg